These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

965 related articles for article (PubMed ID: 9525605)

  • 21. Multiple determinants are involved in HIV coreceptor use as demonstrated by CCR4/CCL22 interaction in peripheral blood mononuclear cells (PBMCs).
    Agrawal L; Vanhorn-Ali Z; Alkhatib G
    J Leukoc Biol; 2002 Nov; 72(5):1063-74. PubMed ID: 12429730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. No detection of CD4-independent human immunodeficiency virus 1 envelope glycoproteins in brain tissue of patients with or without neurological complications.
    Quitadamo B; Peters PJ; Koch M; Luzuriaga K; Cheng-Mayer C; Clapham PR; Gonzalez-Perez MP
    Arch Virol; 2019 Feb; 164(2):473-482. PubMed ID: 30415390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intestinal macrophages display reduced permissiveness to human immunodeficiency virus 1 and decreased surface CCR5.
    Li L; Meng G; Graham MF; Shaw GM; Smith PD
    Gastroenterology; 1999 May; 116(5):1043-53. PubMed ID: 10220496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytolysis by CCR5-using human immunodeficiency virus type 1 envelope glycoproteins is dependent on membrane fusion and can be inhibited by high levels of CD4 expression.
    LaBonte JA; Madani N; Sodroski J
    J Virol; 2003 Jun; 77(12):6645-59. PubMed ID: 12767984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased CCR5 affinity and reduced CCR5/CD4 dependence of a neurovirulent primary human immunodeficiency virus type 1 isolate.
    Gorry PR; Taylor J; Holm GH; Mehle A; Morgan T; Cayabyab M; Farzan M; Wang H; Bell JE; Kunstman K; Moore JP; Wolinsky SM; Gabuzda D
    J Virol; 2002 Jun; 76(12):6277-92. PubMed ID: 12021361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CCR5 expression correlates with susceptibility of maturing monocytes to human immunodeficiency virus type 1 infection.
    Naif HM; Li S; Alali M; Sloane A; Wu L; Kelly M; Lynch G; Lloyd A; Cunningham AL
    J Virol; 1998 Jan; 72(1):830-6. PubMed ID: 9420295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kinetic factors control efficiencies of cell entry, efficacies of entry inhibitors, and mechanisms of adaptation of human immunodeficiency virus.
    Platt EJ; Durnin JP; Kabat D
    J Virol; 2005 Apr; 79(7):4347-56. PubMed ID: 15767435
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemokine/CD4 receptor density ratios correlate with HIV replication in lymph node and peripheral blood of HIV-infected individuals.
    Nokta MA; Li XD; Nichols J; Mallen M; Pou A; Asmuth D; Pollard RB
    AIDS; 2001 Jan; 15(2):161-9. PubMed ID: 11216923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human Mast cell progenitors can be infected by macrophagetropic human immunodeficiency virus type 1 and retain virus with maturation in vitro.
    Bannert N; Farzan M; Friend DS; Ochi H; Price KS; Sodroski J; Boyce JA
    J Virol; 2001 Nov; 75(22):10808-14. PubMed ID: 11602722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective HIV-1-induced downmodulation of CD4 and coreceptors.
    Chenine AL; Sattentau Q; Moulard M
    Arch Virol; 2000; 145(3):455-71. PubMed ID: 10795515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potent inhibition of HIV-1 infectivity in macrophages and lymphocytes by a novel CCR5 antagonist.
    Simmons G; Clapham PR; Picard L; Offord RE; Rosenkilde MM; Schwartz TW; Buser R; Wells TN; Proudfoot AE
    Science; 1997 Apr; 276(5310):276-9. PubMed ID: 9092481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.
    Irlbeck DM; Amrine-Madsen H; Kitrinos KM; Labranche CC; Demarest JF
    AIDS; 2008 Jul; 22(12):1425-31. PubMed ID: 18614865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
    Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycosphingolipids promote entry of a broad range of human immunodeficiency virus type 1 isolates into cell lines expressing CD4, CXCR4, and/or CCR5.
    Hug P; Lin HM; Korte T; Xiao X; Dimitrov DS; Wang JM; Puri A; Blumenthal R
    J Virol; 2000 Jul; 74(14):6377-85. PubMed ID: 10864648
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemokine coreceptor usage by diverse primary isolates of human immunodeficiency virus type 1.
    Zhang L; He T; Huang Y; Chen Z; Guo Y; Wu S; Kunstman KJ; Brown RC; Phair JP; Neumann AU; Ho DD; Wolinsky SM
    J Virol; 1998 Nov; 72(11):9307-12. PubMed ID: 9765480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biological analysis of human immunodeficiency virus type 1 R5 envelopes amplified from brain and lymph node tissues of AIDS patients with neuropathology reveals two distinct tropism phenotypes and identifies envelopes in the brain that confer an enhanced tropism and fusigenicity for macrophages.
    Peters PJ; Bhattacharya J; Hibbitts S; Dittmar MT; Simmons G; Bell J; Simmonds P; Clapham PR
    J Virol; 2004 Jul; 78(13):6915-26. PubMed ID: 15194768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A quantitative affinity-profiling system that reveals distinct CD4/CCR5 usage patterns among human immunodeficiency virus type 1 and simian immunodeficiency virus strains.
    Johnston SH; Lobritz MA; Nguyen S; Lassen K; Delair S; Posta F; Bryson YJ; Arts EJ; Chou T; Lee B
    J Virol; 2009 Nov; 83(21):11016-26. PubMed ID: 19692480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting of HIV- and SIV-infected cells by CD4-chemokine receptor pseudotypes.
    Endres MJ; Jaffer S; Haggarty B; Turner JD; Doranz BJ; O'Brien PJ; Kolson DL; Hoxie JA
    Science; 1997 Nov; 278(5342):1462-4. PubMed ID: 9367958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenotypic Correlates of HIV-1 Macrophage Tropism.
    Arrildt KT; LaBranche CC; Joseph SB; Dukhovlinova EN; Graham WD; Ping LH; Schnell G; Sturdevant CB; Kincer LP; Mallewa M; Heyderman RS; Rie AV; Cohen MS; Spudich S; Price RW; Montefiori DC; Swanstrom R
    J Virol; 2015 Nov; 89(22):11294-311. PubMed ID: 26339058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD4-independent infection of two CD4(-)/CCR5(-)/CXCR4(+) pre-T-cell lines by human and simian immunodeficiency viruses.
    Borsetti A; Parolin C; Ridolfi B; Sernicola L; Geraci A; Ensoli B; Titti F
    J Virol; 2000 Jul; 74(14):6689-94. PubMed ID: 10864687
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 49.